CESCA Therapeutics is a biotechnology company developing cellular therapies, medicinal delivery systems, and regenerative medicines that is headquartered in Rancho Cordova, California and was founded in 1986 by Philip H. Coelho.
CESCA Therapeutics changed its name to ThermoGenesis in 2019 to showcase their strategy and capabilities of providing cellular manufacturing tools and services. The company offers clinical biobanking, point-of-care solutions, cellular processing, and has developed solutions such as their X-Lab System Start-Up Kit, their X-WASH System Start-Up Kit, PXP System Start-Up Kit, and their X-MINI CD3 Selection Kit.
Their X-Lab System Start-Up Kit, X-WASH System Start-Up Kit, and PXP System Start-Up Kit all include control modules, a docking station, their Datatrak Software, counterweights, and X-balance rings.
ThermoGenesis is interested in providing their products and services to blood banks, hospitals, researchers, and clinicians. Their products are designed to extract bone marrow with a reliable system, and to advance cell therapies for clinics.